Supplementary Table 3. Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines
收藏future-science-group.figshare.com2024-05-15 更新2025-03-26 收录
下载链接：
https://future-science-group.figshare.com/articles/dataset/Supplementary_Table_3_Real-world_data_on_treatment_outcomes_in_EGFR-mutant_non-small-cell_lung_cancer_patients_receiving_osimertinib_in_second_or_further_lines/14595807/1
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Table 3.
Real world data on treatment outcomes in EGFR mutant NSCLC patients receiving
osimertinib in second or further lines
Cox regression univariate
and multivariate analysis including all covariates potentially impacting on
overall survival.
补充表 3. 接受奥希替尼二线或后续治疗方案治疗 EGFR 突变非小细胞肺癌患者的治疗结果之现实世界数据。包括所有可能影响总生存期的协变量的单因素和多因素 Cox 回归分析。
提供机构：
Taylor & Francis
